Affiliations 

  • 1 Future Industries Institute, University of South Australia, Mawson Lakes 5095, Australia
  • 2 Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Minden Penang 11800, Pulau Pinang, Malaysia
  • 3 Department of Gynaecological Oncology, Royal Adelaide Hospital, North Terrace, Adelaide 5000, Australia
  • 4 Personalised Oncology Division, The Walter and Eliza Hall Institute of Medial Research, Parkville 3052, Australia
  • 5 Department of Women's Health, Tübingen University Hospital, Calwerstr. 7, 72076 Tübingen, Germany
  • 6 Computational Learning Systems Laboratory, UniSA STEM, University of South Australia, Mawson Lakes 5095, Australia
Cancers (Basel), 2021 Oct 27;13(21).
PMID: 34771551 DOI: 10.3390/cancers13215388

Abstract

Matrix assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) can determine the spatial distribution of analytes such as protein distributions in a tissue section according to their mass-to-charge ratio. Here, we explored the clinical potential of machine learning (ML) applied to MALDI MSI data for cancer diagnostic classification using tissue microarrays (TMAs) on 302 colorectal (CRC) and 257 endometrial cancer (EC)) patients. ML based on deep neural networks discriminated colorectal tumour from normal tissue with an overall accuracy of 98% in balanced cross-validation (98.2% sensitivity and 98.6% specificity). Moreover, our machine learning approach predicted the presence of lymph node metastasis (LNM) for primary tumours of EC with an accuracy of 80% (90% sensitivity and 69% specificity). Our results demonstrate the capability of MALDI MSI for complementing classic histopathological examination for cancer diagnostic applications.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.